Zhang Sheng, President of TTGG retains the title of "40U40 Outstanding Young Investors in China"

TTGG Portfolio High-end Light Source Chips and Optical Devices R&D Company HGC (Wuhan) Technology completed Series B2 Round of Financing, Accelerating the Establishment of a Global Light Source Resear

TTGG Actively Supports the Development of Key Industries in Wuhan Optics Valley

TTGG invested in Cingular Biotechnology, China's Leading Innovative R&D Enterprise of Biological Prosthetic Heart Valves

TTGG: We Aim to Support Strong Industrial Chains, Strengthen Areas of Weakness in Chains, and Extend Chains to Promote the High-quality Development of the Real Economy.

Yongan Futures (600927), a Portfolio Company of TTGG, Has Set a Benchmark in the Futures Industry by Getting Listed on the Shanghai Stock Exchange.